Search alternatives:
significant cases » significant cause (Expand Search), significant based (Expand Search), significant causal (Expand Search)
changes decrease » larger decrease (Expand Search), change increases (Expand Search), largest decrease (Expand Search)
cases increased » rate increased (Expand Search), levels increased (Expand Search)
Showing 61 - 80 results of 43,353 for search '(( significant cases increased ) OR ( significant changes decrease ))', query time: 1.44s Refine Results
  1. 61
    All–age cases and age–standardised incidence, prevalence, mortality, DALYs and corresponding AAPC for RA in China and world in 1990 and 2021.

    All–age cases and age–standardised incidence, prevalence, mortality, DALYs and corresponding AAPC for RA in China and world in 1990 and 2021. by Zhengpeng Li (2322058)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 62
    Total tau levels are significantly decreased in the healthy older brains compared to the younger brains.

    Total tau levels are significantly decreased in the healthy older brains compared to the younger brains. by Shreyasi Chatterjee (3531506)

    Published 2023
    Save to List
    Saved in:
  3. 63
    Estimated annual percentage changes in the prevalence rate of specific gynecological diseases from 1990 to 2021, categorized by age group and SDI.

    Estimated annual percentage changes in the prevalence rate of specific gynecological diseases from 1990 to 2021, categorized by age group and SDI. by Xiaofeng He (2618752)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 64
    Transepithelial resistance of NHBE decreases significantly after PAA exposure.

    Transepithelial resistance of NHBE decreases significantly after PAA exposure. by Ellie S. Burns (21246537)

    Published 2025
    Save to List
    Saved in:
  5. 65
    Frequencies of peripheral blood immune cells with each profile in SVR and non-SVR cases for DCV/ASV treatment.

    Frequencies of peripheral blood immune cells with each profile in SVR and non-SVR cases for DCV/ASV treatment. by Miyabi Miura (18605126)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  6. 66
    The global prevalence of gynecological diseases among women aged 15-49 years in 1990 and 2021, along with the trends and changes observed between these years.

    The global prevalence of gynecological diseases among women aged 15-49 years in 1990 and 2021, along with the trends and changes observed between these years. by Xiaofeng He (2618752)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 67
    Estimated changes in risk of leptospirosis, Salvador, Brazil, 1996–2010.

    Estimated changes in risk of leptospirosis, Salvador, Brazil, 1996–2010. by Marcelo Cunha (12400935)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  8. 68
    Frequencies of peripheral blood immune cells with each profile in the SVR cases before and after OBV/PTV/r treatment.

    Frequencies of peripheral blood immune cells with each profile in the SVR cases before and after OBV/PTV/r treatment. by Miyabi Miura (18605126)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 69
    Changes in the monthly contamination rate (per set) in blood culture (BC).

    Changes in the monthly contamination rate (per set) in blood culture (BC). by Miki Doi (15347878)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  10. 70
    Significant changes in whole-brain voxelwise analysis.

    Significant changes in whole-brain voxelwise analysis. by José V. Pardo (8293983)

    Published 2020
    Save to List
    Saved in:
  11. 71
    Geniposide (Gen) significantly decreased the content of Hyp in bleomycin-induced PF mice’s lung tissue.

    Geniposide (Gen) significantly decreased the content of Hyp in bleomycin-induced PF mice’s lung tissue. by Jian-Bin Yin (19556105)

    Published 2024
    Save to List
    Saved in:
  12. 72
    Prevalence of gynecological diseases (GDs) among women of childbearing age in 2021, along with their changes from 1990 to 2021, and the contribution of each GD to the overall prevalence, by 21 GBD regions.

    Prevalence of gynecological diseases (GDs) among women of childbearing age in 2021, along with their changes from 1990 to 2021, and the contribution of each GD to the overall preva... by Xiaofeng He (2618752)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 73
    Frequencies of peripheral blood immune cells with each profile in SVR patients before and after OBV/PTV/r therapy by paired comparison analysis for each patient.

    Frequencies of peripheral blood immune cells with each profile in SVR patients before and after OBV/PTV/r therapy by paired comparison analysis for each patient. by Miyabi Miura (18605126)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  14. 74
    Consolidated standard of reporting trials (CONSORT) diagram.

    Consolidated standard of reporting trials (CONSORT) diagram. by Miyabi Miura (18605126)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 75
    TBX21 determination from candidate genes by PD-1+Treg- or PD-1+CD8+-related immune profile.

    TBX21 determination from candidate genes by PD-1+Treg- or PD-1+CD8+-related immune profile. by Miyabi Miura (18605126)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  16. 76
    Raw data of frequencies of peripheral blood immune cells with each profile for DCV/ASV treatment.

    Raw data of frequencies of peripheral blood immune cells with each profile for DCV/ASV treatment. by Miyabi Miura (18605126)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 77
    Frequencies of peripheral blood immune cells with each profile in the non-SVR group before and after OBV/PTV/r therapy.

    Frequencies of peripheral blood immune cells with each profile in the non-SVR group before and after OBV/PTV/r therapy. by Miyabi Miura (18605126)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 78
    Frequencies of peripheral blood immune cells with each profile in all patients before and after OBV/PTV/r therapy by paired comparison analysis for each patient.

    Frequencies of peripheral blood immune cells with each profile in all patients before and after OBV/PTV/r therapy by paired comparison analysis for each patient. by Miyabi Miura (18605126)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 79
    Frequencies of peripheral blood immune cells with each profile in patients before and after DCV/ASV therapy.

    Frequencies of peripheral blood immune cells with each profile in patients before and after DCV/ASV therapy. by Miyabi Miura (18605126)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 80
    Consolidated standard of reporting trials (CONSORT) diagram.

    Consolidated standard of reporting trials (CONSORT) diagram. by Miyabi Miura (18605126)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: